Damiana (Herb/Suppl)

Brand and Other Names:Mexican damiana, turnera aphrodisiaca, more...turnera diffusa
  • Print

Suggested Dosing

No typical dosage recommendations

Classical dosage of the leaf was 2 g

Next:

Suggested Uses

headache, bedwetting, depression, nervous dyspepsia, atonic constipation, for prophylaxis and treatment of sexual disturbances, strengthening and stimulation during exertion, boosting and maintaining mental and physical capacity, and as an aphrodisiac

Efficacy

Insufficient reliable information to rate efficacy

Previous
Next:

Interactions

Interaction Checker

and Damiana

No Results

     activity indicator 
    No Interactions Found
    Interactions Found

    Contraindicated

      Serious - Use Alternative

        Significant - Monitor Closely

          Minor

            All Interactions Sort By:
             activity indicator 

            Contraindicated (0)

              Serious - Use Alternative (0)

                Monitor Closely (0)

                  Minor (23)

                  • acarbose

                    damiana decreases effects of acarbose by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.

                  • chlorpropamide

                    damiana decreases effects of chlorpropamide by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.

                  • glimepiride

                    damiana decreases effects of glimepiride by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.

                  • glipizide

                    damiana decreases effects of glipizide by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.

                  • glyburide

                    damiana decreases effects of glyburide by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.

                  • insulin aspart

                    damiana decreases effects of insulin aspart by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.

                  • insulin detemir

                    damiana decreases effects of insulin detemir by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.

                  • insulin glargine

                    damiana decreases effects of insulin glargine by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.

                  • insulin glulisine

                    damiana decreases effects of insulin glulisine by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.

                  • insulin lispro

                    damiana decreases effects of insulin lispro by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.

                  • insulin NPH

                    damiana decreases effects of insulin NPH by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.

                  • insulin regular human

                    damiana decreases effects of insulin regular human by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.

                  • metformin

                    damiana decreases effects of metformin by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.

                  • miglitol

                    damiana decreases effects of miglitol by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.

                  • nateglinide

                    damiana decreases effects of nateglinide by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.

                  • pioglitazone

                    damiana decreases effects of pioglitazone by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.

                  • repaglinide

                    damiana decreases effects of repaglinide by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.

                  • rosiglitazone

                    damiana decreases effects of rosiglitazone by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.

                  • saxagliptin

                    damiana decreases effects of saxagliptin by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.

                  • sitagliptin

                    damiana decreases effects of sitagliptin by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.

                  • tolazamide

                    damiana decreases effects of tolazamide by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.

                  • tolbutamide

                    damiana decreases effects of tolbutamide by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.

                  • vildagliptin

                    damiana decreases effects of vildagliptin by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.

                  Previous
                  Next:

                  Adverse Effects

                  None reported

                  Previous
                  Next:

                  Warnings

                  Contraindications

                  None reported

                  Cautions

                  Excessive doses may cause insomnia & headache

                  Previous
                  Next:

                  Pregnancy & Lactation

                  Pregnancy Category: no harmful effects known

                  Lactation: no harmful effects known

                  Pregnancy Categories

                  A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.

                  B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.

                  C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.

                  D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.

                  X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.

                  NA: Information not available.

                  Previous
                  Next:

                  Pharmacology

                  Metabolism: N/A

                  Excretion: N/A

                  Mechanism of Action

                  Reportedly has stimulant, antidepressant, thymoleptic, testosteromimetic, euphoric & nervous restorative properties

                  Previous
                  Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.